Market Cap 39.94M
Revenue (ttm) 101.49M
Net Income (ttm) -480,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -0.47%
Debt to Equity Ratio 0.28
Volume 349,400
Avg Vol 1,773,806
Day's Range N/A - N/A
Shares Out 34.43M
Stochastic %K 31%
Beta 1.73
Analysts Strong Sell
Price Target $4.00

Company Profile

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 248 960 9009
Fax: 248 960 9119
Address:
30142 South Wixom road, Wixom, United States
Mallingan
Mallingan Oct. 22 at 11:34 PM
$RMTI Davita Q3 October 29th
1 · Reply
Mallingan
Mallingan Oct. 22 at 11:49 AM
$RMTI Only 15 business days left. There's a potential profit surprise if Rockwell replaces all or most of the blocked contaminated Nipro batch, plus the potential news of a major announcement!
0 · Reply
Mallingan
Mallingan Oct. 22 at 11:17 AM
$RMTI https://www.linkedin.com/jobs/search/?currentJobId=4315908120&f_C=481409&geoId=92000000&origin=COMPANY_PAGE_JOBS_CLUSTER_EXPANSION&originToLandingJobPostings=4315908120%2C4289643890%2C4289648737&trk=d_flagship3_company_posts
1 · Reply
Eastwood63
Eastwood63 Oct. 17 at 10:06 PM
$RMTI — Pre-Earnings Setup and Volume Context Today’s trading volume for RMTI was the lowest in the past 39 sessions, suggesting that the float may be tightly held (“locked”) ahead of the upcoming Q3 earnings announcement. This pattern often indicates that investors are waiting for confirmation before repositioning — setting the stage for potentially sharp moves once results are released. Post-Earnings Scenarios: 🔹 Below Expectations: If revenue or margin trends disappoint, sentiment could weaken, and dilution concerns may resurface. Downside risk would likely re-emerge, particularly if management guidance turns cautious. 🔹 Meets Expectations: Delivering results in line with guidance would likely stabilize investor sentiment, helping the stock build a base in the $1.X.30–$1.X.50 range. This would reinforce confidence that the turnaround plan remains intact. 🔹 Beats Expectations:
2 · Reply
Ahdayesh
Ahdayesh Oct. 17 at 5:18 PM
$RMTI at 1.15… I’m not mad, I’m just emotionally exhausted 😩 How long are we supposed to hold? Should I pray, average down, or just light a candle and hope it moons? 🕯️🚀 Give us something, RMTI… we need a win 😭💔
2 · Reply
TheOutsider_
TheOutsider_ Oct. 16 at 5:16 PM
$RMTI I guess I’ve lost all my money in here. Bag holder at 25$
4 · Reply
Eastwood63
Eastwood63 Oct. 16 at 11:48 AM
$RMTI How active/good is RMTI under the current CEO in making contracts? Frequency: Under the current CEO, RMTI has secured approximately 4–6 major contracts or renewals per year over the past three years. Including smaller or mid-sized agreements, that figure rises to around 8–10 annually. Under the current CEO, RMTI has become more disciplined in contracting—favoring long-term deals, reducing reliance on major customers, and improving revenue predictability. Previous management drove faster sales growth but with higher risk from customer concentration. If this trend continues, the current approach should bring greater stability, though full recovery depends on the scale and margins of new contracts versus lost volume.
2 · Reply
Mallingan
Mallingan Oct. 15 at 6:40 PM
$RMTI What do you think about Wednesdays? If I'm not mistaken, there's never been a conference on Wednesdays. Is that a good thing or a bad thing in your opinion? Or is it nothing?
2 · Reply
Eastwood63
Eastwood63 Oct. 14 at 8:52 AM
$RMTI There have been questions and concerns among investors regarding the company's leadership in the past. Specifically, they are wondering whether CEO compensation was misaligned. The answer is yes — particularly during the 2018–2021 cycle. Executives (including Paul, Ellison, and others) received substantial cash and equity awards while the company reported recurring multi-year losses and relied on dilutive financing. Has that misalignment in compensation begun to change? The answer is yes. There is evidence of improved operational performance in 2023–2024 under Strobeck’s leadership, including higher sales, record gross profit, and adjusted EBITDA profitability in 2024. That suggests governance and execution have improved — but it doesn’t erase the prior years’ compensation decisions and dilution. Fiscal year 2025 is not over yet. The company's liquidity position provides a buffer, but sustained financial health will depend on successful customer retention and acquisition strategies
2 · Reply
Mallingan
Mallingan Oct. 11 at 5:53 PM
$RMTI My children, don't worry. If the company were to go bankrupt, I have enough beds, food, and water for everyone!
2 · Reply
Latest News on RMTI
Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:28 AM EDT - 2 months ago

Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript


Rockwell Medical Announces Second Quarter 2025 Results

Aug 14, 2025, 6:00 AM EDT - 2 months ago

Rockwell Medical Announces Second Quarter 2025 Results


Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:01 AM EDT - 6 months ago

Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript


Rockwell Medical Announces First Quarter 2025 Results

May 12, 2025, 6:00 AM EDT - 6 months ago

Rockwell Medical Announces First Quarter 2025 Results


Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 9:36 AM EDT - 7 months ago

Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript


Rockwell Medical Promotes Jesse Neri to Chief Financial Officer

Dec 12, 2024, 6:00 AM EST - 11 months ago

Rockwell Medical Promotes Jesse Neri to Chief Financial Officer


Rockwell Medical Expands Distribution in the Philippines

Nov 19, 2024, 6:00 AM EST - 1 year ago

Rockwell Medical Expands Distribution in the Philippines


Rockwell Medical's Dip Gives A Speculative Opportunity

Nov 13, 2024, 7:25 AM EST - 1 year ago

Rockwell Medical's Dip Gives A Speculative Opportunity


Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:30 AM EST - 1 year ago

Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript


Rockwell Medical: The Turnaround Is Looking Real

Sep 15, 2024, 2:06 PM EDT - 1 year ago

Rockwell Medical: The Turnaround Is Looking Real


Returning To Rockwell Medical: Buy At 65% Of Revenue

Nov 30, 2023, 1:42 AM EST - 2 years ago

Returning To Rockwell Medical: Buy At 65% Of Revenue


Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 9:58 AM EST - 2 years ago

Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript


Rockwell Medical Announces Third Quarter 2023 Results

Nov 14, 2023, 6:00 AM EST - 2 years ago

Rockwell Medical Announces Third Quarter 2023 Results


Mallingan
Mallingan Oct. 22 at 11:34 PM
$RMTI Davita Q3 October 29th
1 · Reply
Mallingan
Mallingan Oct. 22 at 11:49 AM
$RMTI Only 15 business days left. There's a potential profit surprise if Rockwell replaces all or most of the blocked contaminated Nipro batch, plus the potential news of a major announcement!
0 · Reply
Mallingan
Mallingan Oct. 22 at 11:17 AM
$RMTI https://www.linkedin.com/jobs/search/?currentJobId=4315908120&f_C=481409&geoId=92000000&origin=COMPANY_PAGE_JOBS_CLUSTER_EXPANSION&originToLandingJobPostings=4315908120%2C4289643890%2C4289648737&trk=d_flagship3_company_posts
1 · Reply
Eastwood63
Eastwood63 Oct. 17 at 10:06 PM
$RMTI — Pre-Earnings Setup and Volume Context Today’s trading volume for RMTI was the lowest in the past 39 sessions, suggesting that the float may be tightly held (“locked”) ahead of the upcoming Q3 earnings announcement. This pattern often indicates that investors are waiting for confirmation before repositioning — setting the stage for potentially sharp moves once results are released. Post-Earnings Scenarios: 🔹 Below Expectations: If revenue or margin trends disappoint, sentiment could weaken, and dilution concerns may resurface. Downside risk would likely re-emerge, particularly if management guidance turns cautious. 🔹 Meets Expectations: Delivering results in line with guidance would likely stabilize investor sentiment, helping the stock build a base in the $1.X.30–$1.X.50 range. This would reinforce confidence that the turnaround plan remains intact. 🔹 Beats Expectations:
2 · Reply
Ahdayesh
Ahdayesh Oct. 17 at 5:18 PM
$RMTI at 1.15… I’m not mad, I’m just emotionally exhausted 😩 How long are we supposed to hold? Should I pray, average down, or just light a candle and hope it moons? 🕯️🚀 Give us something, RMTI… we need a win 😭💔
2 · Reply
TheOutsider_
TheOutsider_ Oct. 16 at 5:16 PM
$RMTI I guess I’ve lost all my money in here. Bag holder at 25$
4 · Reply
Eastwood63
Eastwood63 Oct. 16 at 11:48 AM
$RMTI How active/good is RMTI under the current CEO in making contracts? Frequency: Under the current CEO, RMTI has secured approximately 4–6 major contracts or renewals per year over the past three years. Including smaller or mid-sized agreements, that figure rises to around 8–10 annually. Under the current CEO, RMTI has become more disciplined in contracting—favoring long-term deals, reducing reliance on major customers, and improving revenue predictability. Previous management drove faster sales growth but with higher risk from customer concentration. If this trend continues, the current approach should bring greater stability, though full recovery depends on the scale and margins of new contracts versus lost volume.
2 · Reply
Mallingan
Mallingan Oct. 15 at 6:40 PM
$RMTI What do you think about Wednesdays? If I'm not mistaken, there's never been a conference on Wednesdays. Is that a good thing or a bad thing in your opinion? Or is it nothing?
2 · Reply
Eastwood63
Eastwood63 Oct. 14 at 8:52 AM
$RMTI There have been questions and concerns among investors regarding the company's leadership in the past. Specifically, they are wondering whether CEO compensation was misaligned. The answer is yes — particularly during the 2018–2021 cycle. Executives (including Paul, Ellison, and others) received substantial cash and equity awards while the company reported recurring multi-year losses and relied on dilutive financing. Has that misalignment in compensation begun to change? The answer is yes. There is evidence of improved operational performance in 2023–2024 under Strobeck’s leadership, including higher sales, record gross profit, and adjusted EBITDA profitability in 2024. That suggests governance and execution have improved — but it doesn’t erase the prior years’ compensation decisions and dilution. Fiscal year 2025 is not over yet. The company's liquidity position provides a buffer, but sustained financial health will depend on successful customer retention and acquisition strategies
2 · Reply
Mallingan
Mallingan Oct. 11 at 5:53 PM
$RMTI My children, don't worry. If the company were to go bankrupt, I have enough beds, food, and water for everyone!
2 · Reply
b44fox
b44fox Oct. 10 at 8:38 PM
$RMTI bought a little bit at 1.12, will by buy morning it drops below 1.05
3 · Reply
AHRMA
AHRMA Oct. 10 at 6:17 PM
$RMTI I have invested and traded RMTI for a bit over 25 years. I have shared thoughts and interpretations on this site and the previous Yahoo finance forums for most of that 25 years. During most of those 25 years the forums have been very active, with many postings from countless individuals every single day. The message volume this year is by far the lowest it has ever been. I see this as a clear reflection of investor disinterest in holding or trading RMTI. Understandable really. The company has repeatedly damaged and disappointed investors. I see no reason to believe this will change this year or in 2026. I think we may see the occasional small and momentary spikes but no sustainable increase in PPS
1 · Reply
Mallingan
Mallingan Oct. 9 at 10:27 PM
$RMTI Quiet Period!! With approximately 20 days to go until the Q3 conference call, it's unlikely Rockwell will announce any major news before then. It's more realistic to expect that, if anything significant is announced, it will be announced directly during the conference call to maximize its impact and market attention. If, however, no significant announcements are made during the Q3 conference call, they are unlikely to arrive immediately afterward, considering that Q4 already ends in December. In this case, any updates would likely be postponed until early 2026, in January, coinciding with the start of the new Q1 quarter. However, since the CEO has stated the goal of closing a deal by the end of Q4, there are still two months left—November and December—in which an announcement could be made. If nothing is announced by the end of December, the aforementioned plans could be delayed or, in the worst-case scenario, never materialize.
2 · Reply
Eastwood63
Eastwood63 Oct. 9 at 10:35 AM
$RMTI These Are Recent and Ongoing Contracts Under the Existing Management. Some of these contracts are a three-year partnership. Innovative Renal Care (IRC) Date Announced: July 8, 2025 Sanderling Renal Services Date Announced: September 28, 2023 Centers for Dialysis Care (CDC) Date Announced: October 3, 2023 Nipro Medical Corporation Date Announced: September 3, 2024 Nephro Group Dialysis Centers Date Announced: November 19, 2024 These agreements reflect Rockwell Medical's ongoing efforts to expand its customer base and ensure a stable revenue stream.
1 · Reply
Eastwood63
Eastwood63 Oct. 8 at 9:22 PM
$RMTI isn't out of business. They have some good management. Management has shown ability to hit some targets before. They achieved adjusted EBITDA profitability in 2024. They had record net sales, gross profit for several years, showing there is capacity for growth. You can search for RMTI's Recent and Ongoing Contracts on internet to realize RMTI working on new contracts. Can share price go further down? my answer is I DON'T KNOW.
1 · Reply
Will_Trade_For_Money
Will_Trade_For_Money Oct. 8 at 7:30 PM
$RMTI just caught the article about the investment relations lady that got promoted...so basically drive a 6 something stock down to under a dollar and you get promoted at #rmti.. cool
2 · Reply
Zaens
Zaens Oct. 8 at 2:20 PM
$RMTI I wonder what makes people bullish on such very bad performing stock.
3 · Reply
Russell25
Russell25 Oct. 7 at 9:25 AM
$RMTI this needs to go like $SPRB
1 · Reply
Uinvestwisely
Uinvestwisely Oct. 6 at 9:17 PM
$RMTI ….I still think that we will turn soon …since CC is coming up Rockwell can not announce anything significant right now…Zack still has BUY rating of 2.
1 · Reply
Mallingan
Mallingan Oct. 3 at 4:34 PM
$RMTI https://www.linkedin.com/posts/rockwell-medical_nowhiring-hiring-jobopening-activity-7379901786276646912-0m7i?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAADGSFI8BRv_P2MiAQAoyVKxcuxsTbNWqrvM&utm_campaign=copy_link
0 · Reply
Eastwood63
Eastwood63 Oct. 2 at 7:12 PM
$RMTI Exactly one month ago there were 900K shares left to sell short. Today a little more than 6M shares are available for short selling. Shorts are now gradually exiting positions to lock in profits without spiking the price. Bearish momentum might be exhausting if Short Interest keep Decreasing = Potential for Reversal.
1 · Reply
truthdotphd
truthdotphd Oct. 2 at 1:19 AM
$RMTI $2.0 soon!
1 · Reply